Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A European, Prospective, Non-Interventional Study to Assess Health Related Quality of Life and to Identify Key Transitional Life Events in Patients With Moderate or Severe Haemophilia A Using Helixate NexGen

NCT01053715 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT01053715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01053715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A European, Prospective, Non-Interventional Study to Assess Health Related Quality of Life and to Identify Key Transitional Life Events in Patients With Moderate or Severe Haemophilia A Using Helixate NexGen
Lead sponsor
CSL Behring
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
January 31, 2015
Enrollment
78 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a